- From: Ian Horrocks <ian.horrocks@comlab.ox.ac.uk>
- Date: Thu, 29 Jan 2009 15:59:41 +0000
- To: public-owl-comments@w3.org
- Cc: Sam Brandt <sam.brandt@siemens.com>
Sam Brandt has kindly given me permission to forward this email to the public-owl-comments list. Begin forwarded message: > From: "Brandt, Sam (H USA)" <sam.brandt@siemens.com> > Date: 29 January 2009 14:27:40 GMT > To: <ian.horrocks@comlab.ox.ac.uk> > Cc: "Alan Rector" <rector@cs.man.ac.uk> > Subject: Support for OWL 2 > > Ian, > > I have been asked by Alan Rector to communicate Siemen's support > for ongoing efforts to develop OWL2. > > Siemens Healthcare is one of the world‘s largest suppliers to the > healthcare industry. > The company is a renowned medical solutions provider with core > competence > and innovative strength in diagnostic and therapeutic technologies, > as well as > knowledge engineering, including information technology and system > integration. > Siemens Healthcare delivers solutions across the entire continuum > of care — > from prevention and early detection, to diagnosis, therapy, and care. > > Our Health Services division is investigating the use of OWL 2 for > knowledge-driven > architectures to build the next generation of IT solutions for > health-care. From our > perspective, the change from OWL 1 to OWL 2 constitutes a welcome > step in the right > direction. OWL 2 makes it easier to model our application domain > and and gives us > more choices to establish links between the ontology and the > application environment. > > In particular, exact cardinality restrictions, property chain > inclusions, and n-ary datatypes > make it possible to create OWL-based ontologies that represent the > healthcare domain > more in keeping with the perspective of health-care professionals. > In order to bridge the > gap between ontologies and actual health-care applications we > consider rich annotation > facilities a very important feature. The introduction of axiom > annotations in OWL 2 is > therefore very useful. > > We fully encourage the further evolution of OWL 2 and believe that > it may represent a critical enabling > technology in the provision of Personalized Medicine, and the > achievement of fully integrated, patient-centric care. > Thank you for your efforts in this regard, and please feel free to > call on me if I can be of further assistance. > > Sincerely, > > Sam Brandt MD > > > ____________________________________________ > SIEMENS Medical Solutions - Health Services > Sam Brandt, MD > Chief Medical Informatics Officer > 51 Valley Stream Parkway, Malvern, PA, 19355-1406 > Phone: +1 610 219 5701 > Fax: +1 610 219 3510 > Mobile: +1 610 745 5291 > E-Mail: sam.brandt@siemens.com > Admin: Hannelore Kahles; +1 (610) 219-4530 > hannelore.kahles@siemens.com > > ---------------------------------------------------------------------- > ------ This message and any included attachments are from Siemens > Medical Solutions and are intended only for the addressee(s). The > information contained herein may include trade secrets or > privileged or otherwise confidential information. Unauthorized > review, forwarding, printing, copying, distributing, or using such > information is strictly prohibited and may be unlawful. If you > received this message in error, or have reason to believe you are > not authorized to receive it, please promptly delete this message > and notify the sender by e-mail with a copy to > Central.SecurityOffice@siemens.com Thank you
Received on Thursday, 29 January 2009 16:00:36 UTC